Addiction

Opioid prescription decreased substantially in 2 years following 2016 CDC guideline for prescribing opioids for chronic pain.

BUP associated with lower likelihood of any opioid use among participants with mood disorders, without mental disorder, compared to MET.

Gerald Sacks, MD, and Fariborz Rezai, MD, FCCP FCCM, share their approach to selecting PAMORAs in clinical practice for the optimal management of opioid-induced constipation.

Potential public health benefit of OAT linked to 50% lower risk of all-cause mortality.

Data show 1 in 5 surgical patients who receive prescriptions for benzodiazepine go on to use them persistently.

The reduction in heavy drinking in individuals between 18-25 years old is likely due to government restrictions on social gatherings.

Stress induced by COVID-19 is driving opioid addiction risks. An expert weighs in on addressing one matter to resolve another.

Weekly number of opioid-related deaths increased 135% over study period.

A longer duration of medication use during pregnancy was linked to decreases in odds of overdose and preterm birth.

Veterans are particularly susceptible to opioid dependence and abuse.

A daily opioid dose higher than 90 MME is associated with 3-fold risk increase, compared to 90 MME or lower.

Incidence rates decreased by nearly half after direct-acting antiviral treatment regimen.

Data show sublingual sufentanil tablets did not affect pain scores, but did benefit patient satisfaction outcomes.

Data show a nearly 30% reduction in individuals filling naloxone prescriptions at the start of COVID-19 pandemic, with no significant recovery observed.

The treatment shows superior results over bupivacine solution, with a significant number of patients becoming opioid-free.

A new study compares patients self-reported outcomes after depot or daily sublingual buprenorphine treatment, including satisfaction and burden rates.

A recent JAMA study shows a decrease in suicide deaths between 2019-2020, despite a 17% overall increase in mortality.